Status
Conditions
Treatments
About
To study the effect of neuroendocrine dysfunctions on bone health in obesity
Full description
It is a multicentric, observational, cross-sectional non-profit study with additional procedures. The study will include obese patients (BMI>30) with and without hyper functioning pituitary adenomas (acromegaly, Cushing and prolactinoma) and hypopituitarism (GH deficiency, secondary hypogonadism) aimed at studying the effect of metabolic phenotypes of obesity and neuroendocrine dysfunctions on bone health.
Patients enrollment will take place in Ospedale San Raffaele, Azienda Ospedaliera Universitaria Federico II di Napoli and UOC Endocrinologia-AOU Renato Dulbecco, Università degli Studi di Catanzaro Magna Graecia.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria for subjects with pituitary disease:
Inclusion criteria for subjects without pituitary disease
Exclusion Criteria:
150 participants in 2 patient groups
Loading...
Central trial contact
Luigi Di Filippo, medical doctor; Andrea Giustina, professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal